Methacrylic Acid

Methacrylic Acid

SCHEMBL1921401

C=C(C)C(=O)O.OCCCc1ccncc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP4A11 Q02928 2/20 0.42
PPARA Q07869 1/20 0.42
HRH1 P35367 2/20 0.41
ALDH1A1 P00352 1/20 0.40
THRA P10827 1/20 0.40
THRB P10828 1/20 0.40
TSHR P16473 1/20 0.38
CYP4F2 P78329 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 1/20 0.38
CA2 P00918 1/20 0.38
KMT2A Q03164 1/20 0.37
FFAR1 O14842 1/20 0.37
LOXL2 Q9Y4K0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL1921991 0.94 HRH1 (0.46) CYP4A11HRH1ALDH1A1THRATHRB
SCHEMBL279761 0.82 HRH1 (0.56) CYP4A11HRH1ALDH1A1CA2LOXL2
SCHEMBL26116262 0.80 HRH1 (0.54) CYP4A11HRH1ALDH1A1CA2LOXL2
4-(2-Hydroxyethyl)Pyridine SCHEMBL9518668 0.78 TDP1 (0.48) CYP4A11PPARAALDH1A1TSHRCYP4F2
SCHEMBL16610464 0.78 HRH1 (0.42) HRH1THRATHRBTSHRSMN1; SMN2
Ethylamine SCHEMBL6992203 0.77 HRH1 (0.57) CYP4A11HRH1ALDH1A1TSHRSMN1; SMN2
SCHEMBL9164808 0.77 NPC1 (0.50) CYP4A11HRH1ALDH1A1SMN1; SMN2NPC1
SCHEMBL9068837 0.76 HDAC3 (0.44) HRH1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL4444401 0.76 HRH1 (0.59) CYP4A11HRH1ALDH1A1CYP4F2CA2
SCHEMBL14335950 0.75 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9156088-B2 Au—Ag core-shell nanorod particles and method for producing same TOKYO UNIVERSITY OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2015-10-13 US disclosed
US-8658735-B2 Polymerizable monomer, graft copolymer, and surface modifier TOKYO UNIVERSITY OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2014-02-25 US disclosed
EP-2511028-A1 AU-AG CORE-SHELL NANOROD PARTICLES AND METHOD FOR PRODUCING SAME Tokyo University Of Science Educational Foundation Administrative Organization (JP) 2012-10-17 EP disclosed
US-20120244225-A1 Au-Ag Core-Shell Nanorod Particles and Method for Producing Same TOKYO UNIVERSITY OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2012-09-27 US disclosed
US-20110269905-A1 Polymerizable Monomer, Graft Copolymer, and Surface Modifier TOKYO UNIVERSITY OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2011-11-03 US disclosed
EP-2330138-A1 POLYMERIZABLE MONOMER, GRAFT COPOLYMER, AND SURFACE MODIFIER Tokyo University Of Science Educational Foundation Administrative Organization (JP) 2011-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269905-A1 Polymerizable Monomer, Graft Copolymer, and Surface Modifier ITGA1, CHRM1, C3AR1 CYP4A11 1511/4885PPARA 869/4885HRH1 1899/4885
US-20120244225-A1 Au-Ag Core-Shell Nanorod Particles and Method for Producing Same GRB7, AUP1, AGPS CYP4A11 3301/4885PPARA 3239/4885HRH1 2657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.